Free Trial

UpHealth (UPHL) Competitors

$0.0002 0.00 (0.00%)
As of 10/8/2025 03:39 PM Eastern

UPHL vs. BTTX, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, and TALKW

Should you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Better Therapeutics (BTTX), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry.

UpHealth vs. Its Competitors

UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

UpHealth has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Better Therapeutics Neutral

56.1% of UpHealth shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Better Therapeutics has lower revenue, but higher earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M-$1.350.00
Better TherapeuticsN/AN/A-$39.76MN/AN/A

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Better Therapeutics N/A N/A N/A

Summary

Better Therapeutics beats UpHealth on 3 of the 5 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$4K$59.21M$6.09B$22.02B
Dividend YieldN/AN/A5.69%3.58%
P/E Ratio0.00N/A85.5529.86
Price / Sales0.001.62537.7964.52
Price / CashN/A4.0237.9224.43
Price / Book0.001.1512.994.64
Net Income-$56.42M-$30.80M$3.30B$1.01B
7 Day PerformanceN/A-4.87%4.33%0.44%
1 Month PerformanceN/A-38.82%9.48%3.13%
1 Year PerformanceN/A-25.55%84.61%15.30%

UpHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/A$0.00
flat
N/A-99.6%$4K$130M0.001,750
BTTX
Better Therapeutics
N/A$0.00
flat
N/AN/A$5KN/A0.0040
OPGN
OpGen
N/AN/AN/AN/A$1K$2.67M0.00100
ACONW
Aclarion
N/A$0.03
-2.0%
N/A+2.7%$0.00$62.95K0.007Positive News
Gap Down
AONC
American Oncology Network
N/A$8.95
+5.3%
N/A+184.8%$0.00$1.34B0.001,520Gap Down
DHACW
Digital Health Acquisition
N/A$0.02
-0.6%
N/AN/A$0.00N/A0.00N/A
FMS
Fresenius Medical Care AG & Co. KGaA
3.7863 of 5 stars
$26.66
+1.2%
$27.80
+4.3%
+35.4%$0.00$20.63B21.851,384News Coverage
Analyst Upgrade
Gap Up
LFMDP
LifeMD
N/A$23.94
+0.4%
N/A+5.9%$0.00$245.56M0.00230High Trading Volume
OTRKP
Ontrak
N/A$0.04
+75.0%
N/A-86.0%$0.00$10.84M0.00250Gap Down
High Trading Volume
PIIIW
P3 Health Partners
N/A$0.01
+21.5%
N/A-67.9%$0.00$1.46B0.00500Positive News
Gap Down
TALKW
Talkspace
N/A$0.05
+3.2%
N/A-50.0%$0.00$202.61M0.00500Positive News
Gap Up

Related Companies and Tools


This page (NYSE:UPHL) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners